Menstruation recovery in scar pregnancy patients undergoing UAE and curettage and its influencing factors
This study aims to investigate the menstrual recovery outcome of scar pregnancy patients who received uterine artery embolization combined with curettage, and its influencing factors.The data of 119 patients with scar pregnancy, who received uterine artery embolization combined with curettage betwee...
Gespeichert in:
| Veröffentlicht in: | Medicine (Baltimore) 2018-03, Vol.97 (11), p.e9584-e9584 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e9584 |
|---|---|
| container_issue | 11 |
| container_start_page | e9584 |
| container_title | Medicine (Baltimore) |
| container_volume | 97 |
| creator | Cao, Guang-Shao Liu, Rui-Qing Liu, Yu-Yan Liu, Jian-Wen Li, Lu-Peng Zhang, Qiang Cao, Hui-Cun Li, Tian-Xiao |
| description | This study aims to investigate the menstrual recovery outcome of scar pregnancy patients who received uterine artery embolization combined with curettage, and its influencing factors.The data of 119 patients with scar pregnancy, who received uterine artery embolization combined with curettage between December 2012 and December 2016 in Henan Provincival People's Hospital, were collected. The menstruation recovery of these patients was followed up, and factors that have influence on menstrual blood volume were analyzed using SPSS V.17.0.Follow-up data were available in 101/119 (84.9%) women. The median follow-up time was 22.7 months (range: 1.6-50.6 months); 58 (57.4%) patients had reduced menstrual blood volume, and 2 patients (2%) had amenorrhea. The proportion of patients with reduced menstrual blood volume, who were embolized with polyvinyl alcohol (PVA), PVA combined with gelatin sponge, and gelatin sponge between < and ≥33 years old was 41.7% versus 66.7%, 40% versus 57.1% and 60.6% versus 68.0%. The average age of patients with reduced menstrual blood volume (34.3 years) was greater than patients with normal menstrual blood volume (31.4 years), but the difference was not statistically significant (P = .07).Reduced menstrual blood volume can occur in scar pregnancy patients who received uterine artery embolization combined with curettage. The influence of the embolic agent PVA on menstrual blood volume depends on age, but the difference was not statistically significant. |
| doi_str_mv | 10.1097/MD.0000000000009584 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5882401</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2014144456</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4502-9cdc71aa201734a3d202b60214ebd33f1e330451ef729239552cfecc1546c1253</originalsourceid><addsrcrecordid>eNpdkUtP3DAUhS1EVabT_gIk5CWbUD-TeIOEgD4kRt2UteVxbjKGjD3YDmj-PYYBBHhzZd_vnnvkg9AhJSeUqObn4uKEvDtKtmIPzajkdSVVLfbRjBAmq0Y14gB9S-mGEMobJr6iA6YkbxmtZ8gtwKccJ5Nd8DiCDfcQt9h5nKyJeBNh8MbbLd4UAnxOePIdxCE4P-Drs0tsfIftFCFnM8DzzRXI-X6cwNsnqjc2h5i-oy-9GRP8eKlzdP3r8v_5n-rq3--_52dXlRWSsErZzjbUGEZow4XhHSNsWRNGBSw7znsKnBMhKfQNU4wrKZntwVoqRW0pk3yOTne6m2m5hs4W09GMehPd2sStDsbpjx3vVnoI91q2LRPli-bo-EUghrsJUtZrlyyMo_EQpqSLM0GFELIuKN-hNoaUIvRvayjRTyHpxYX-HFKZOnrv8G3mNZUCiB3wEMYMMd2O0wNEvQIz5tWznmwUq4qRlnBak6q8MMYfAbkrnjs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2014144456</pqid></control><display><type>article</type><title>Menstruation recovery in scar pregnancy patients undergoing UAE and curettage and its influencing factors</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Wolters Kluwer Open Health</source><source>IngentaConnect Free/Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Cao, Guang-Shao ; Liu, Rui-Qing ; Liu, Yu-Yan ; Liu, Jian-Wen ; Li, Lu-Peng ; Zhang, Qiang ; Cao, Hui-Cun ; Li, Tian-Xiao</creator><creatorcontrib>Cao, Guang-Shao ; Liu, Rui-Qing ; Liu, Yu-Yan ; Liu, Jian-Wen ; Li, Lu-Peng ; Zhang, Qiang ; Cao, Hui-Cun ; Li, Tian-Xiao</creatorcontrib><description>This study aims to investigate the menstrual recovery outcome of scar pregnancy patients who received uterine artery embolization combined with curettage, and its influencing factors.The data of 119 patients with scar pregnancy, who received uterine artery embolization combined with curettage between December 2012 and December 2016 in Henan Provincival People's Hospital, were collected. The menstruation recovery of these patients was followed up, and factors that have influence on menstrual blood volume were analyzed using SPSS V.17.0.Follow-up data were available in 101/119 (84.9%) women. The median follow-up time was 22.7 months (range: 1.6-50.6 months); 58 (57.4%) patients had reduced menstrual blood volume, and 2 patients (2%) had amenorrhea. The proportion of patients with reduced menstrual blood volume, who were embolized with polyvinyl alcohol (PVA), PVA combined with gelatin sponge, and gelatin sponge between < and ≥33 years old was 41.7% versus 66.7%, 40% versus 57.1% and 60.6% versus 68.0%. The average age of patients with reduced menstrual blood volume (34.3 years) was greater than patients with normal menstrual blood volume (31.4 years), but the difference was not statistically significant (P = .07).Reduced menstrual blood volume can occur in scar pregnancy patients who received uterine artery embolization combined with curettage. The influence of the embolic agent PVA on menstrual blood volume depends on age, but the difference was not statistically significant.</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000009584</identifier><identifier>PMID: 29538216</identifier><language>eng</language><publisher>United States: The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Abortion, Legal - adverse effects ; Abortion, Legal - methods ; Adult ; Blood Loss, Surgical - prevention & control ; Cesarean Section - adverse effects ; Cicatrix - etiology ; Cicatrix - pathology ; Cicatrix - physiopathology ; Curettage - adverse effects ; Curettage - methods ; Female ; Humans ; Long Term Adverse Effects - diagnosis ; Menstruation Disturbances - diagnosis ; Menstruation Disturbances - etiology ; Observational Study ; Postoperative Complications - diagnosis ; Postoperative Complications - physiopathology ; Pregnancy ; Pregnancy, Ectopic - diagnosis ; Pregnancy, Ectopic - surgery ; Recovery of Function ; Uterine Artery Embolization - methods ; Uterine Rupture - etiology ; Uterine Rupture - prevention & control</subject><ispartof>Medicine (Baltimore), 2018-03, Vol.97 (11), p.e9584-e9584</ispartof><rights>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.</rights><rights>Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4502-9cdc71aa201734a3d202b60214ebd33f1e330451ef729239552cfecc1546c1253</citedby><cites>FETCH-LOGICAL-c4502-9cdc71aa201734a3d202b60214ebd33f1e330451ef729239552cfecc1546c1253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882401/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882401/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29538216$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cao, Guang-Shao</creatorcontrib><creatorcontrib>Liu, Rui-Qing</creatorcontrib><creatorcontrib>Liu, Yu-Yan</creatorcontrib><creatorcontrib>Liu, Jian-Wen</creatorcontrib><creatorcontrib>Li, Lu-Peng</creatorcontrib><creatorcontrib>Zhang, Qiang</creatorcontrib><creatorcontrib>Cao, Hui-Cun</creatorcontrib><creatorcontrib>Li, Tian-Xiao</creatorcontrib><title>Menstruation recovery in scar pregnancy patients undergoing UAE and curettage and its influencing factors</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>This study aims to investigate the menstrual recovery outcome of scar pregnancy patients who received uterine artery embolization combined with curettage, and its influencing factors.The data of 119 patients with scar pregnancy, who received uterine artery embolization combined with curettage between December 2012 and December 2016 in Henan Provincival People's Hospital, were collected. The menstruation recovery of these patients was followed up, and factors that have influence on menstrual blood volume were analyzed using SPSS V.17.0.Follow-up data were available in 101/119 (84.9%) women. The median follow-up time was 22.7 months (range: 1.6-50.6 months); 58 (57.4%) patients had reduced menstrual blood volume, and 2 patients (2%) had amenorrhea. The proportion of patients with reduced menstrual blood volume, who were embolized with polyvinyl alcohol (PVA), PVA combined with gelatin sponge, and gelatin sponge between < and ≥33 years old was 41.7% versus 66.7%, 40% versus 57.1% and 60.6% versus 68.0%. The average age of patients with reduced menstrual blood volume (34.3 years) was greater than patients with normal menstrual blood volume (31.4 years), but the difference was not statistically significant (P = .07).Reduced menstrual blood volume can occur in scar pregnancy patients who received uterine artery embolization combined with curettage. The influence of the embolic agent PVA on menstrual blood volume depends on age, but the difference was not statistically significant.</description><subject>Abortion, Legal - adverse effects</subject><subject>Abortion, Legal - methods</subject><subject>Adult</subject><subject>Blood Loss, Surgical - prevention & control</subject><subject>Cesarean Section - adverse effects</subject><subject>Cicatrix - etiology</subject><subject>Cicatrix - pathology</subject><subject>Cicatrix - physiopathology</subject><subject>Curettage - adverse effects</subject><subject>Curettage - methods</subject><subject>Female</subject><subject>Humans</subject><subject>Long Term Adverse Effects - diagnosis</subject><subject>Menstruation Disturbances - diagnosis</subject><subject>Menstruation Disturbances - etiology</subject><subject>Observational Study</subject><subject>Postoperative Complications - diagnosis</subject><subject>Postoperative Complications - physiopathology</subject><subject>Pregnancy</subject><subject>Pregnancy, Ectopic - diagnosis</subject><subject>Pregnancy, Ectopic - surgery</subject><subject>Recovery of Function</subject><subject>Uterine Artery Embolization - methods</subject><subject>Uterine Rupture - etiology</subject><subject>Uterine Rupture - prevention & control</subject><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUtP3DAUhS1EVabT_gIk5CWbUD-TeIOEgD4kRt2UteVxbjKGjD3YDmj-PYYBBHhzZd_vnnvkg9AhJSeUqObn4uKEvDtKtmIPzajkdSVVLfbRjBAmq0Y14gB9S-mGEMobJr6iA6YkbxmtZ8gtwKccJ5Nd8DiCDfcQt9h5nKyJeBNh8MbbLd4UAnxOePIdxCE4P-Drs0tsfIftFCFnM8DzzRXI-X6cwNsnqjc2h5i-oy-9GRP8eKlzdP3r8v_5n-rq3--_52dXlRWSsErZzjbUGEZow4XhHSNsWRNGBSw7znsKnBMhKfQNU4wrKZntwVoqRW0pk3yOTne6m2m5hs4W09GMehPd2sStDsbpjx3vVnoI91q2LRPli-bo-EUghrsJUtZrlyyMo_EQpqSLM0GFELIuKN-hNoaUIvRvayjRTyHpxYX-HFKZOnrv8G3mNZUCiB3wEMYMMd2O0wNEvQIz5tWznmwUq4qRlnBak6q8MMYfAbkrnjs</recordid><startdate>20180301</startdate><enddate>20180301</enddate><creator>Cao, Guang-Shao</creator><creator>Liu, Rui-Qing</creator><creator>Liu, Yu-Yan</creator><creator>Liu, Jian-Wen</creator><creator>Li, Lu-Peng</creator><creator>Zhang, Qiang</creator><creator>Cao, Hui-Cun</creator><creator>Li, Tian-Xiao</creator><general>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</general><general>Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180301</creationdate><title>Menstruation recovery in scar pregnancy patients undergoing UAE and curettage and its influencing factors</title><author>Cao, Guang-Shao ; Liu, Rui-Qing ; Liu, Yu-Yan ; Liu, Jian-Wen ; Li, Lu-Peng ; Zhang, Qiang ; Cao, Hui-Cun ; Li, Tian-Xiao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4502-9cdc71aa201734a3d202b60214ebd33f1e330451ef729239552cfecc1546c1253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Abortion, Legal - adverse effects</topic><topic>Abortion, Legal - methods</topic><topic>Adult</topic><topic>Blood Loss, Surgical - prevention & control</topic><topic>Cesarean Section - adverse effects</topic><topic>Cicatrix - etiology</topic><topic>Cicatrix - pathology</topic><topic>Cicatrix - physiopathology</topic><topic>Curettage - adverse effects</topic><topic>Curettage - methods</topic><topic>Female</topic><topic>Humans</topic><topic>Long Term Adverse Effects - diagnosis</topic><topic>Menstruation Disturbances - diagnosis</topic><topic>Menstruation Disturbances - etiology</topic><topic>Observational Study</topic><topic>Postoperative Complications - diagnosis</topic><topic>Postoperative Complications - physiopathology</topic><topic>Pregnancy</topic><topic>Pregnancy, Ectopic - diagnosis</topic><topic>Pregnancy, Ectopic - surgery</topic><topic>Recovery of Function</topic><topic>Uterine Artery Embolization - methods</topic><topic>Uterine Rupture - etiology</topic><topic>Uterine Rupture - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cao, Guang-Shao</creatorcontrib><creatorcontrib>Liu, Rui-Qing</creatorcontrib><creatorcontrib>Liu, Yu-Yan</creatorcontrib><creatorcontrib>Liu, Jian-Wen</creatorcontrib><creatorcontrib>Li, Lu-Peng</creatorcontrib><creatorcontrib>Zhang, Qiang</creatorcontrib><creatorcontrib>Cao, Hui-Cun</creatorcontrib><creatorcontrib>Li, Tian-Xiao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cao, Guang-Shao</au><au>Liu, Rui-Qing</au><au>Liu, Yu-Yan</au><au>Liu, Jian-Wen</au><au>Li, Lu-Peng</au><au>Zhang, Qiang</au><au>Cao, Hui-Cun</au><au>Li, Tian-Xiao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Menstruation recovery in scar pregnancy patients undergoing UAE and curettage and its influencing factors</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2018-03-01</date><risdate>2018</risdate><volume>97</volume><issue>11</issue><spage>e9584</spage><epage>e9584</epage><pages>e9584-e9584</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>This study aims to investigate the menstrual recovery outcome of scar pregnancy patients who received uterine artery embolization combined with curettage, and its influencing factors.The data of 119 patients with scar pregnancy, who received uterine artery embolization combined with curettage between December 2012 and December 2016 in Henan Provincival People's Hospital, were collected. The menstruation recovery of these patients was followed up, and factors that have influence on menstrual blood volume were analyzed using SPSS V.17.0.Follow-up data were available in 101/119 (84.9%) women. The median follow-up time was 22.7 months (range: 1.6-50.6 months); 58 (57.4%) patients had reduced menstrual blood volume, and 2 patients (2%) had amenorrhea. The proportion of patients with reduced menstrual blood volume, who were embolized with polyvinyl alcohol (PVA), PVA combined with gelatin sponge, and gelatin sponge between < and ≥33 years old was 41.7% versus 66.7%, 40% versus 57.1% and 60.6% versus 68.0%. The average age of patients with reduced menstrual blood volume (34.3 years) was greater than patients with normal menstrual blood volume (31.4 years), but the difference was not statistically significant (P = .07).Reduced menstrual blood volume can occur in scar pregnancy patients who received uterine artery embolization combined with curettage. The influence of the embolic agent PVA on menstrual blood volume depends on age, but the difference was not statistically significant.</abstract><cop>United States</cop><pub>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>29538216</pmid><doi>10.1097/MD.0000000000009584</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0025-7974 |
| ispartof | Medicine (Baltimore), 2018-03, Vol.97 (11), p.e9584-e9584 |
| issn | 0025-7974 1536-5964 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5882401 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Wolters Kluwer Open Health; IngentaConnect Free/Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
| subjects | Abortion, Legal - adverse effects Abortion, Legal - methods Adult Blood Loss, Surgical - prevention & control Cesarean Section - adverse effects Cicatrix - etiology Cicatrix - pathology Cicatrix - physiopathology Curettage - adverse effects Curettage - methods Female Humans Long Term Adverse Effects - diagnosis Menstruation Disturbances - diagnosis Menstruation Disturbances - etiology Observational Study Postoperative Complications - diagnosis Postoperative Complications - physiopathology Pregnancy Pregnancy, Ectopic - diagnosis Pregnancy, Ectopic - surgery Recovery of Function Uterine Artery Embolization - methods Uterine Rupture - etiology Uterine Rupture - prevention & control |
| title | Menstruation recovery in scar pregnancy patients undergoing UAE and curettage and its influencing factors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A29%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Menstruation%20recovery%20in%20scar%20pregnancy%20patients%20undergoing%20UAE%20and%20curettage%20and%20its%20influencing%20factors&rft.jtitle=Medicine%20(Baltimore)&rft.au=Cao,%20Guang-Shao&rft.date=2018-03-01&rft.volume=97&rft.issue=11&rft.spage=e9584&rft.epage=e9584&rft.pages=e9584-e9584&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000009584&rft_dat=%3Cproquest_pubme%3E2014144456%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2014144456&rft_id=info:pmid/29538216&rfr_iscdi=true |